Pfizer Inc. bounced back in a big way from a GLP-1 trip-up this spring by making known its plan to take over what Metsera Inc ...

Experts agree that the earlier Alzheimer's disease is detected, the sooner action can be taken. And so, the key to preventing ...

MBX Biosciences Inc. posted positive top-line phase II study data in treating chronic hypoparathyroidism, positioning itself to take on a U.S. FDA-approved therapy for the rare endocrine disease.

Genfit SA is discontinuing its VS-01 program in acute-on-chronic liver failure (ACLF), and has decided to reprioritize ...

Two recent studies should provide comfort to medical device manufacturers who develop tools and devices for bariatric surgery. Patients who undergo bariatric surgery lost nearly three times more ...

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agilent Technologies, Astrazeneca, Femasys, Immunovia, Lunit, Medical Electronic Systems, ...

Chinese Academy of Sciences researchers have patented heptanoate compounds reported to be useful for the treatment of amyotrophic lateral sclerosis, Alzheimer’s, Parkinson’s and Huntington’s disease.

Nanjing Leads Biolabs Co. Ltd. has received IND approval from the FDA for LBL-047, its first autoimmune therapeutic candidate to enter the clinic.

The second day’s meeting of the U.S. CDC’s Advisory Committee for Immunization Practices (ACIP) took up guidelines related to COVID-19 vaccines, of which an outspoken skeptic is Health and Human ...

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Cookie Settings ...

A committee of the House of Representatives advanced a bill that if passed will give eligible breakthrough medical devices ...

The U.S. FDA cleared 18 drugs in August, comparable to July’s 17 but down from June’s 23 approvals. That brings the 2025 U.S.